Compare Amylx Pharmaceuticals Inc (AMLX) vs Five9 Inc (FIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Five9 Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $17.45 (market cap $1.98B), while Five9 Inc trades at $25.84 (market cap $1.95B). The key difference: Amylx Pharmaceuticals Inc and Five9 Inc are close in size by market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Five9 Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | FIVN | |
|---|---|---|
Market Cap | $1.98B | $1.95B |
Sector | Health | Technology |
52-Week High | $18.70 | $29.16 |
52-Week Low | $7.64 | $13.61 |
Enterprise Value | $1.70B | $2.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →
